Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer

Cancer Investigation

Volumn 27, Issue 9, 2009, Pages 885-890

  Kuderer, Nicole M ^a,b   Lyman, Gary H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MEDICAL INFORMATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ODDS RATIO; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350155229     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903275142     Document Type: Article

References (23)

1. Altman, D.G.; Lyman, G.H. Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat 1998, 52, 289-303.
2. Laird, M.M.; Mosteller, F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 1990, 6, 5-30.
3. Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman D. Measuring inconsistency in meta- analyses. Brit Med J 2003, 327, 557-560.
4. DerSimonian, R.; Laird, N.M. Meta-analysis in clinical trials. Contr Clin Trials 1986, 7, 177-188.
5. van't Veer, L.J.; Dai, H.; van De Vijver, M.J.; et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415, 530-536.
6. van De Vijver, M.J.; He, Y.D.; van't Veer, L.J.; et al. A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347, 1999-2009.
7. Ahr, A.; Karn, T.; Solbach, C.; et al. Identification of high risk breastcancer patients by gene expression profiling. Lancet 2002, 359, 131-132. (Pubitemid 34112543)
8. Bertucci, F.; Nasser, V.; Granjeaud, S.; et al. Gene expression profiles of poor prognosis primary breast cancer correlate with survival. Hum Mol Genet 2002, 11, 863-872.
9. Huang, E.; Cheng, S.H.; Dressman, H.; et al. Gene expression predictors of breast cancer outcomes. Lancet 2003, 361, 1590-1596.
10. Iwao, K.; Matoba, R.; Ueno, N.; et al. Molecular classification of primary breast tumors possessing distinct prognostic properties. Hum Mol Genet 2002, 11, 199-206.
11. Paik, S.; Shak, S.; Tang, G.; et al. A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer. N Engl J Med 2004, 351, 2817-2826.
12. Esteva, F.J.; Sahin, A.A.; Coombes, L.; et al. Multi-gene RTPCR assay for predicting recurrence in node-negative breast cancer patients that did not receive adjuvant tamoxifen nor chemotherapy. Breast Cancer Res Treat 2004, 88(suppl l), 1- 253.
13. Esteva, F.J.; Sahin, A.A.; Cristofanilli, M.; et al. Prognostic role of a multi-gene RT-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin Cancer Res 2005, 104, 676-681.
14. Wang, Y.; Klijn, J.G.M.; Zhang, Y.; et al. Gene-expression profiles to predict distant metastasis of lymph-node negative primary breast cancer. Lancet 2005, 365, 671-679.
15. Simon, R.; Radmacher, M.D.; Dobbin, K.; McShane, L.M. Pitfalls in the use of DNA micro-array data for diagnostic and prognostic classification. J Natl Cancer Inst 2003, 95, 14-18.
16. Ntzani, E.E.; loannidis JPA. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 2003, 362, 1439-1444.
17. Simon, R. Diagnostic and prognostic prediction using gene expression profiles in high- dimensional microarray data. Brit J Cancer 2003, 89, 1599-1604.
18. Lyman, G.H.; Djulbegovic, B. The challenge of systematic reviews in cancer screening, diagnostic and staging studies. Cancer Treat Rev 2005, 31, 628-639.
19. Deeks, J.J. Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001, 323, 157-162.
20. Vamvakas, E. Meta-analysis of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods. Arch Pathol Lab Med 1998, 122, 675-686.
21. Irwig, L.; Tosteson, A.N.A.; Gatsonis, C.; et al. Guidelines for metaanalysis evaluating diag nostic tests. Ann Intern Med 1994, 120, 667-676.
22. Shepes, S.B.; Schechter,M.T. The assessment of diagnostic tests. J Am Med Assoc 1984, 252(17), 2418-2422.
23. Lyman, G.H.; Kuderer, N.M. The strengths and limitations of meta-analyses based on aggregate patient data. BMC Med Res Methodol 2005, 5(14), 1-7.